Astrotech Revenue Growth Rates (ASTC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Astrotech Corp  (NASDAQ: ASTC)
 

ASTC's Revenue Growth by Quarter and Year

Astrotech's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ASTC/growth
https://api.csimarket.com/api/v1/companies/ASTC/fundamentals
https://api.csimarket.com/api/v1/companies/ASTC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ASTC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 0.27
FY 0.27

ASTCs Annual Revenue
Astrotech's Revenue in the fiscal year 2026 $ 0.91 millions
Astrotech's Revenue in the fiscal year 2025 $ 1.05 millions
Astrotech's Revenue in the fiscal year 2024 $ 1.66 millions
Astrotech's Revenue in the fiscal year 2023 $ 0.75 millions
Astrotech's Revenue in the fiscal year 2022 $ 0.87 millions




ASTC Revenue first quarter 2026 Y/Y Growth Comment
Astrotech Corp reported decrease in Revenue in the first quarter 2026 by -8.67% to $ 0.27 millions, from the same quarter in 2025.
The decrease in the first quarter 2026 Astrotech Corp's Revenue compares unfavorably to the Company's average Revenue rise of 29.7%.

Looking into first quarter 2026 results within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue growth. While Astrotech Corp' s Revenue decline of -8.67% ranks overall at the positon no. 1054 in the first quarter 2026.


ASTC Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September -8.67 %
FY   -

Financial Statements
Astrotech's first quarter 2026 Revenue $ 0.27 millions ASTC's Income Statement
Astrotech's first quarter 2025 Revenue $ 0.30 millions Quarterly ASTC's Income Statement


ASTC Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 110.77 %
FY (Year on Year)   -


Back to ASTC Growth rate Comparisons >> Back to ASTC Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #203
Overall #1054

Revenue Y/Y Growth Statistics
High Average Low
456.67 % 29.7 % -96.88 %
(Mar 31 2024)   (Jun 30 2015)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #203
Overall #1054
Revenue Y/Y Growth Statistics
High Average Low
456.67 % 29.7 % -96.88 %
(Mar 31 2024)   (Jun 30 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Astrotech's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
20400 % 442.65 % -100 %
(Dec 31 2019)  


ASTC's I. Quarter Q/Q Revenue Comment
Astrotech Corp achieved in the I. Quarter 2026 below company average Revenue doubling of 110.77% quarter on quarter, to $ 0.27 millions.

I. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 36.36% in the I. Quarter a year ago.

Within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Astrotech's Revenue growth quarter on quarter, overall rank is 3759.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #549
Overall #3759
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #549
Overall #3759
Revenue Q/Q Growth Statistics
High Average Low
20400 % 442.65 % -100 %
(Dec 31 2019)  


ASTC's I. Quarter Q/Q Revenue Comment
Astrotech Corp achieved in the I. Quarter 2026 below company average Revenue doubling of 110.77% quarter on quarter, to $ 0.27 millions.

I. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 36.36% in the I. Quarter a year ago.

Within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Astrotech's Revenue growth quarter on quarter, overall rank is 3759.


Astrotech's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.91
Y / Y Revenue Growth (TTM) -12.87 %
Year on Year Revenue Growth Overall Ranking # 3578
Seqeuential Revenue Change (TTM) -9.33 %
Seq. Revenue Growth (TTM) Overall Ranking # 1052


Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Astrotech reported a decline in Revenue by -12.87% year on year, to $1 millions, compare to the 11.63% growth at Mar 31 2026.

In the Healthcare sector 482 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 110 to 3578.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 3
Healthcare Sector # 483
Overall # 3578

Revenue TTM Y/Y Growth Statistics
High Average Low
456.67 %
 29.7 %
-96.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 202
S&P 500 # 1052
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Astrotech reported a decline in Revenue by -12.87% year on year, to $1 millions, compare to the 11.63% growth at Mar 31 2026.

In the Healthcare sector 482 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 110 to 3578.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 3
Healthcare Sector # 483
Overall # 3578

Revenue TTM Y/Y Growth Statistics
High Average Low
456.67 %
29.7 %
-96.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 202
S&P 500 # 1052




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ASTC's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Viatris Inc -0.28%$ -0.277 millions
Zoetis Inc -0.38%$ -0.375 millions
Pfizer Inc-0.43%$ -0.426 millions
Standard Biotools Inc -0.51%$ -0.508 millions
Lucid Diagnostics Inc -0.66%$ -0.661 millions
Globus Medical Inc -0.69%$ -0.693 millions
Conmed Corporation-0.70%$ -0.701 millions
Surgery Partners Inc -0.75%$ -0.755 millions
Myriad Genetics Inc -1.03%$ -1.025 millions
Lensar Inc -1.29%$ -1.292 millions
Fortrea Holdings Inc -1.40%$ -1.397 millions
Immunocore Holdings Plc-1.42%$ -1.419 millions
Pacira Biosciences inc -1.59%$ -1.595 millions
Organon and Co -1.75%$ -1.748 millions
Teva Pharmaceutical Industries Limited-1.90%$ -1.897 millions
Skinhealth Systems Inc -2.07%$ -2.071 millions
Charles River Laboratories International inc -2.20%$ -2.201 millions
Inogen Inc -2.40%$ -2.399 millions
Novavax inc -3.05%$ -3.048 millions
Seer Inc -3.14%$ -3.139 millions
Teladoc Health Inc -3.41%$ -3.406 millions
Scientific Industries Inc -3.50%$ -3.504 millions
Cg Oncology Inc -3.72%$ -3.721 millions
Treace Medical Concepts Inc -3.91%$ -3.905 millions
Sarepta Therapeutics Inc -4.51%$ -4.509 millions
Pacific Health Care Organization Inc-4.69%$ -4.689 millions
Tela Bio Inc -5.06%$ -5.058 millions
Perrigo Company Plc-5.22%$ -5.225 millions
Heron Therapeutics Inc -5.49%$ -5.493 millions
Milestone Scientific Inc -5.95%$ -5.948 millions


About Astrotech Revenue Growth Rates (ASTC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Astrotech Corp (CIK 1001907).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-036951
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Astrotech Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.